Thiamine Injection Shortage

• • Fresenius Kabi did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Mylan Institutional did not provide a reason for the shortage.
  • Sagent had thiamine injection on shortage due to manufacturing delays.

• • Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
  • Thiamine injection, Hikma, 100 mg/mL, 2 mL vial, 25 count, NDC 00641-6228-25
  • Thiamine injection, Mylan Institutional, 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
  • Thiamine injection, Sagent, 100 mg/mL, 2 mL vial, 25 count, NDC 25021-0500-02

Estimated Resupply Dates

• • All marketed presentations are available.